A carregar...
COVID-19 vaccines in multiple sclerosis treated with cladribine or ocrelizumab
Since the recent approval of vaccines against COVID-19, efficacy concerns emerged for MS patients treated with immunosuppressive drugs. We report our experience in four patients, under cladribine (two) or under ocrelizumab (two) treatment, all with low lymphocyte count, three of them vaccinated afte...
Na minha lista:
| Publicado no: | Mult Scler Relat Disord |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier B.V.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8093161/ https://ncbi.nlm.nih.gov/pubmed/33990054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2021.102983 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|